C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/073 (2010.01) C12N 5/071 (2010.01) A01N 1/02 (2006.01) A61K 35/23 (2006.01) A61K 35/50 (2006.01) C12N 1/04 (2006.01)
Patent
CA 2741420
The present invention relates generally to amniotic fluid derived renal progenitor cells positive for CD24 and OB-cadherin and subpopulations thereof, as well as methods of isolating and uses thereof. The invention is further directed to preventing and treating kidney damage with a population of amniotic fluid derived c-kit positive stem cells. Image
La présente invention concerne de manière générale des cellules progénitrices rénales dérivées du liquide amniotique positives à CD24 et à la cadhérine OB et aux sous-populations de ces dernières, ainsi que des procédés d'isolation et des utilisations de ces cellules. L'invention concerne également la prévention et le traitement de lésions rénales par une population de cellules souches c-kit positives dérivées du liquide amniotique.
de Filippo Roger
Perin Laura
Warburton David
Children's Hospital Los Angeles
Ridout & Maybee Llp
LandOfFree
Amniotic fluid cells and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amniotic fluid cells and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amniotic fluid cells and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1704226